Robin Löving, Chief Scientific Officer (CSO) at Salipro Biotech. Robin has more than 15 years’ experience working with therapeutically interesting membrane proteins. He did his PhD with a focus on membrane proteins and antigen design at the Karolinska Institute in Stockholm, Sweden. After being involved in other biotech startup companies, he joined Salipro Biotech as CSO six years ago. Robin’s work has resulted into numerous granted patents and peer-reviewed publications.